Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

Draining HIV Viral Reservoirs: Abivax Prepares ABX464 Cure For Phase IIb

July 5, 2018

Draining HIV Viral Reservoirs: Abivax Prepares ABX464 Cure For Phase IIb

Pharmaphorum

July 5, 2018

Study indicates potential breakthrough HIV drug

PMLive

July 5, 2018

Trial data suggest Abivax’ drug may clear latent HIV

Biopharma Dive

July 3, 2018

Abivax up on mixed HIV data

Drug Development Technology

May 31, 2018

Abivax believes it has made progress towards HIV cure

  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 46

References available upon request.

© 2025 All rights reserved by Abivax 07/2024 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn